Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?
Immunogenic cell death
Mitochondrial danger-associated molecular patterns
Mitochondrial metabolism
Tumor-induced immune-escape
Tumor-induced immune-suppression
Journal
Seminars in cell & developmental biology
ISSN: 1096-3634
Titre abrégé: Semin Cell Dev Biol
Pays: England
ID NLM: 9607332
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
28
03
2019
revised:
09
05
2019
accepted:
10
05
2019
pubmed:
18
5
2019
medline:
23
12
2020
entrez:
18
5
2019
Statut:
ppublish
Résumé
Mitochondria have been considered for a long time only as the principal source of building blocks and energy upon aerobic conditions. Recently they emerged as key players in cell proliferation, invasion and resistance to therapy. The most aggressive tumors are able to evade the immune-surveillance. Alterations in the mitochondria metabolism either in cancer cells or in host immune system cells are involved in such tumor-induced immune-suppression. This review will focus on the main mitochondrial dysfunctions in tumor and immune cell populations determining immune-resistance, and on the therapies that may target mitochondrial metabolism and restore a powerful anti-tumor immune-activity.
Identifiants
pubmed: 31100351
pii: S1084-9521(18)30164-2
doi: 10.1016/j.semcdb.2019.05.008
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
80-89Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.